RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Yasuhiro Yamauchi to Disease-Free Survival

This is a "connection" page, showing publications Yasuhiro Yamauchi has written about Disease-Free Survival.
Connection Strength

0.196
  1. Urushiyama H, Jo T, Yasunaga H, Michihata N, Matsui H, Hasegawa W, Takeshima H, Sakamoto Y, Hiraishi Y, Mitani A, Fushimi K, Nagase T, Yamauchi Y. Oral fluorouracil vs vinorelbine plus cisplatin as adjuvant chemotherapy for stage II-IIIA non-small cell lung cancer: Propensity score-matched and instrumental variable analyses. Cancer Med. 2018 10; 7(10):4863-4869.
    View in: PubMed
    Score: 0.159
  2. Urushiyama H, Jo T, Yasunaga H, Yamauchi Y, Matsui H, Hasegawa W, Takeshima H, Hiraishi Y, Mitani A, Fushimi K, Nagase T. Adjuvant chemotherapy versus chemoradiotherapy for small cell lung cancer with lymph node metastasis: a retrospective observational study with use of a national database in Japan. BMC Cancer. 2017 Sep 02; 17(1):613.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support